Associated Banc-Corp’s Medpace MEDP Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
– Sell
-386
Closed -$204K – 371
2026
Q2
$204K Buy
+386
New +$178K ﹤0.01% 370
2025
Q4
– Sell
-434
Closed -$223K – 340
2025
Q3
$223K Buy
+434
New +$189K 0.01% 322
2022
Q2
– Sell
-1,261
Closed -$206K – 317
2022
Q1
$206K Buy
1,261
+141
+13% +$23.2K 0.01% 310
2021
Q4
$244K Hold
1,120
– – 0.01% 295
2021
Q3
$212K Buy
+1,120
New +$204K 0.01% 315
2021
Q1
– Sell
-1,548
Closed -$215K – 630
2020
Q4
$215K Buy
1,548
+1,531
+9,006% +$193K 0.01% 356
2020
Q3
$2K Hold
17
– – ﹤0.01% 702
2020
Q2
$2K Buy
+17
New +$1.45K ﹤0.01% 696

Other funds holding MEDP

Associated Banc-Corp's MEDP Position: Q3 2026 in Review

Associated Banc-Corp sold out of Medpace (MEDP) in Q3 2026, closing a stake of 386 shares — an estimated $204K sold.

Associated Banc-Corp first reported a position in MEDP in Q2 2020 and held it in 8 quarters. The position peaked at $244K in Q4 2021. 550 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Associated Banc-Corp reported no remaining Medpace position as of Q3 2026 after selling out during the quarter.
  • Associated Banc-Corp sold 386 Medpace shares in Q3 2026, an estimated $204K.
  • Associated Banc-Corp first reported a position in Medpace in Q2 2020 and held it in 8 quarters.
  • Associated Banc-Corp's Medpace position peaked at $244K in Q4 2021.
  • 550 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Associated Banc-Corp's 13F filing for Q3 2026, filed 30 Oct 2026.